Crossmark Global Holdings, Inc. Bio Techne Corp Transaction History

Crossmark Global Holdings, Inc.

  • $5.49 Billion
  • Q4 2024

A detailed history of Crossmark Global Holdings, Inc. transactions in Bio Techne Corp stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 11,165 shares of TECH stock, worth $683,186. This represents 0.01% of its overall portfolio holdings.

Number of Shares
11,165
Previous 11,165 -0.0%
Holding current value
$683,186
Previous $893,000 9.97%
% of portfolio
0.01%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024
SELL
$70.96 - $82.35 $6,386 - $7,411
-90 Reduced 0.8%
11,165 $893,000
Q2 2024

Jul 29, 2024
SELL
$62.12 - $84.15 $41,371 - $56,043
-666 Reduced 5.59%
11,255 $807,000
Q1 2024

May 13, 2024
BUY
$65.98 - $77.09 $7,059 - $8,248
107 Added 0.91%
11,921 $839,000
Q4 2023

Feb 13, 2024
SELL
$52.83 - $78.22 $44,007 - $65,157
-833 Reduced 6.59%
11,814 $911,000
Q3 2023

Nov 08, 2023
SELL
$67.52 - $89.42 $33,017 - $43,726
-489 Reduced 3.72%
12,647 $878,000
Q2 2023

Jul 31, 2023
SELL
$73.76 - $85.98 $111,230 - $129,657
-1,508 Reduced 10.3%
13,136 $1.1 Million
Q1 2023

May 12, 2023
BUY
$71.62 - $86.62 $245,513 - $296,933
3,428 Added 30.56%
14,644 $1.09 Million
Q4 2022

Jan 19, 2023
BUY
$80.67 - $352.29 $736,597 - $3.22 Million
9,131 Added 437.94%
11,216 $930,000
Q3 2022

Nov 01, 2022
BUY
$282.54 - $391.85 $7,628 - $10,579
27 Added 1.31%
2,085 $592,000
Q2 2022

Jul 29, 2022
BUY
$322.67 - $449.65 $64,534 - $89,930
200 Added 10.76%
2,058 $714,000
Q1 2022

May 11, 2022
SELL
$353.85 - $487.79 $21,231 - $29,267
-60 Reduced 3.13%
1,858 $804,000
Q4 2021

Jan 10, 2022
SELL
$456.15 - $525.06 $1.25 Million - $1.43 Million
-2,730 Reduced 58.73%
1,918 $992,000
Q3 2021

Oct 21, 2021
BUY
$444.87 - $538.88 $2.07 Million - $2.5 Million
4,648 New
4,648 $2.25 Million
Q3 2021

Oct 13, 2021
SELL
$444.87 - $538.88 $1.75 Million - $2.12 Million
-3,943 Closed
0 $0
Q2 2021

Jul 21, 2021
SELL
$387.35 - $450.26 $127,825 - $148,585
-330 Reduced 7.72%
3,943 $1.78 Million
Q1 2021

Apr 15, 2021
SELL
$314.62 - $411.0 $22,023 - $28,770
-70 Reduced 1.61%
4,273 $1.63 Million
Q4 2020

Jan 14, 2021
BUY
$246.9 - $321.87 $17,283 - $22,530
70 Added 1.64%
4,343 $1.38 Million
Q3 2020

Oct 08, 2020
BUY
$232.22 - $282.96 $32,510 - $39,614
140 Added 3.39%
4,273 $1.06 Million
Q2 2020

Aug 14, 2020
BUY
$185.43 - $279.56 $44,503 - $67,094
240 Added 6.16%
4,133 $1.09 Million
Q1 2020

Apr 28, 2020
BUY
$161.17 - $221.51 $12,893 - $17,720
80 Added 2.1%
3,893 $738,000
Q4 2019

Feb 06, 2020
BUY
$189.68 - $222.09 $82,131 - $96,164
433 Added 12.81%
3,813 $837,000
Q3 2019

Oct 09, 2019
SELL
$183.56 - $216.72 $29,553 - $34,891
-161 Reduced 4.55%
3,380 $661,000
Q2 2019

Jul 09, 2019
SELL
$188.72 - $215.43 $17,739 - $20,250
-94 Reduced 2.59%
3,541 $738,000
Q1 2019

May 02, 2019
BUY
$136.09 - $200.44 $28,851 - $42,493
212 Added 6.19%
3,635 $722,000
Q4 2018

Jan 31, 2019
SELL
$132.75 - $203.8 $305,325 - $468,740
-2,300 Reduced 40.19%
3,423 $495,000
Q3 2018

Nov 08, 2018
SELL
$147.44 - $204.11 $198,601 - $274,936
-1,347 Reduced 19.05%
5,723 $1.17 Million
Q2 2018

Jul 31, 2018
BUY
$144.9 - $165.58 $20,286 - $23,181
140 Added 2.02%
7,070 $1.05 Million
Q1 2018

Apr 16, 2018
SELL
$131.46 - $151.04 $197,190 - $226,560
-1,500 Reduced 17.79%
6,930 $1.05 Million
Q4 2017

Feb 05, 2018
BUY
$121.17 - $134.75 $1,211 - $1,347
10 Added 0.12%
8,430 $1.09 Million
Q3 2016

Oct 25, 2017
BUY
N/A
8,420
8,420 $1.02 Million

Others Institutions Holding TECH

# of Institutions
619
Shares Held
156M
Call Options Held
161K
Put Options Held
12.7K
View Full List

About BIO-TECHNE Corp

TECH Quotes by TradingView
  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.4B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Crossmark Global Holdings, Inc. Portfolio

Follow Crossmark Global Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email